Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Govind Ballabh Pant Hospital
Age
2–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with Non Cirrhotic Portal Hypertension (NCPH) presenting to our Liver Diseases Follow-up Clinic with history of hemetemesis and/or malena within the past 6 weeks and proven to have esophageal varices as the bleeding source on upper GI endoscopy
You may not be if
A history of surgery for portal hypertension
Patients already on a EST, EVL, or glue injection program before presenting to our hospital
Patients already on beta blockers for primary prophylaxis of variceal bleed
Severe cardiopulmonary or renal disease
Bradycardia (basal heart rate, \<50 beats per minute \[bpm\]) or complete heart block
A history of severe side effects or contraindications to β- blockers, like bronchial asthma, diabetes mellitus, heart failure, peripheral vascular disease, prostatic hypertrophy, or arterial hypotension (systolic blood pressure \<90 mm Hg)
Refusal to give informed written consent to participate in the trial
Patients bleeding from gastric varices or Portal Hypertensive Gastropathy (PHG).
Patients who had a failure of primary hemostasis during acute bleed were also excluded.
